Partneringdesk Deals Briefings

Partneringdesk™ Deals Briefings

Dealmaking activity of 50 of the top pharmaceutical companies

Partneringdesk™ Deals Briefings provide a comprehensive summary of the deals and alliances announced by fifty of the top pharmaceutical and biotechnology companies in the last five years, in a clear and accessible printable format.

Each report is organised into four chapters:

Chapter 1: Company profile

Chapter 2: Financial data and deals overview

Chapter 3: Summary of deals

Chapter 4: List of deals

Every deal entry includes financial information where disclosed, such as headline values and upfront and milestone payments.

The Partneringdesk Deals Briefings series covers the top fifty companies. The Deals Briefings include deals from subsidiary companies, which may pre-date acquisition.

The 50 pharmaceutical companies within the series are:

Abbott

Akzo Nobel

Alcon Labs

Allergan

Altana

Amgen

AstraZeneca

Barr Pharmaceuticals

Baxter International

Bayer

Biogen Idec

Boehringer Ingelheim

Bristol Myers Squibb

Daiichi

Eisai

Eli Lilly

Forest Labs

Fujisawa

Genzyme

Gilead Sciences

GlaxoSmithKline

Ivax Corporation

Johnson & Johnson

Lundbeck

Merck

Merck KGaA

Mitsubishi Pharmaceuticals

Mylan Labs

Novartis

Novo Nordisk

Ono

Otsuka

Pfizer

Purdue Pharma

Roche

Sankyo

Sanofi-Aventis

Schering AG

Schering Plough

Serono

Shionogi Seiyaku

Shire

Solvay

Takeda

Tanabe Seiyaku

Teva

UCB

Watson

Wyeth

Yamanouchi

Each Partneringdesk Deals Briefing costs $395 and is delivered as a PDF.

Following your order a representative will contact you to confirm which company's you require.

Price